Full name
APOTEFARM SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
47.73.Z - Retail sale of pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.19.Z - Retail trade
47.29.Z - Retail trade
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
52.10.B - Warehousing and storage of other goods
64.99.Z - Other financial services, except insurance and pension funds, not elsewhere classified
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 67,8 | |||
Gross profit (loss) | -0,1 | -0,1 | -0,2 | -54,3 |
EBITDA | 64,9 | |||
Short time liabilities | 12,2 | |||
Income tax | 0 | 0 | -0 | -1468,4 |
Other operating costs | -27,5 | |||
Equity capital | -0,1 | -0,3 | -0,4 | -69,3 |
Operating profit (EBIT) | 58,8 | |||
Assets | 0,6 | 0,8 | 1,1 | 43,7 |
Net profit (loss) | -0,1 | -0,1 | -0,2 | -52 |
Cash | 24,7 | |||
Liabilities and provisions for liabilities | 0,8 | 1 | 1,5 | 50,2 |
Net income from sale | 19,5 | |||
Working assets | 0,5 | 0,7 | 1 | 50,1 |
Other income costs | -10,8 | |||
Basic operational activity income | 3,5 | 3,6 | 4,4 | 22,1 |
Depreciation | -5,9 | |||
% | % | % | p.p. | |
Profitability of capital | 42 200,9 | |||
Equity capital to total assets | -22,3 | -33,8 | -39,8 | -6 |
Gross profit margin | -2,2 | -3,3 | -4,1 | -0,8 |
EBITDA Margin | 2,9 | |||
Days | Days | Days | Days | |
Short term commitment turnover cycle | -5 | |||
Current financial liquidity indicator | -0,1 | |||
Net dept to EBITDA | 0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane